Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Tuesday, December 31, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Tuesday, December 31, 2024 | Latest Paper
Subscribe Now

TRENDING:

Stéphanie Michaud

Dr. Stéphanie Michaud is the president and CEO of BioCanRx. She has more than 20 years of public, government and private sector experience in research and science & technology innovation policy and is a member of the Board of Directors of Research Canada.

Immunotherapy a beacon of hope in Canada’s fight against cancer

  • The gap between treatment and cure underscores the dire need for innovative approaches in our health-care strategy. 
Opinion | BY STéPHANIE MICHAUD | June 5, 2024
Minister of Innovation, Science and Industry François-Philippe Champagne
Minister of Innovation, Science and Industry François-Philippe Champagne
Innovation Minister François-Philippe Champagne announced new funding last week for five organizations through Canada's Strategic Science Fund. With increased resources, BioCanRx can accelerate the translation of lab-based research into real-world applications, writes the network’s president, Dr. Stéphanie Michaud. The Hill Times photograph by Andrew Meade

Immunotherapy a beacon of hope in Canada’s fight against cancer

Opinion | BY STéPHANIE MICHAUD | June 5, 2024
  • The gap between treatment and cure underscores the dire need for innovative approaches in our health-care strategy. 

Immunotherapy a beacon of hope in Canada’s fight against cancer

Opinion | BY STéPHANIE MICHAUD | June 5, 2024
  • The gap between treatment and cure underscores the dire need for innovative approaches in our health-care strategy. 
Minister of Innovation, Science and Industry François-Philippe Champagne
Innovation Minister François-Philippe Champagne announced new funding last week for five organizations through Canada's Strategic Science Fund. With increased resources, BioCanRx can accelerate the translation of lab-based research into real-world applications, writes the network’s president, Dr. Stéphanie Michaud. The Hill Times photograph by Andrew Meade

It’s time to use the C word: cure

  • With more than 233,900 cancer diagnoses and 85,100 cancer deaths expected in 2022, more must be done to move the needle for Canadian cancer
Opinion | BY STéPHANIE MICHAUD | February 6, 2023
There is little doubt that cancer remains the most significant threat to the health and wealth of Canadians, with cancer deaths representing an average of 16.7 years of life lost for each diagnosed Canadian. All sources combined; Canada spends almost $500-million a year on cancer research all in the hope to unravel a path to the C-word—cure. Photograph courtesy of Pexels

It’s time to use the C word: cure

Opinion | BY STéPHANIE MICHAUD | February 6, 2023
  • With more than 233,900 cancer diagnoses and 85,100 cancer deaths expected in 2022, more must be done to move the needle for Canadian cancer

It’s time to use the C word: cure

Opinion | BY STéPHANIE MICHAUD | February 6, 2023
  • With more than 233,900 cancer diagnoses and 85,100 cancer deaths expected in 2022, more must be done to move the needle for Canadian cancer
There is little doubt that cancer remains the most significant threat to the health and wealth of Canadians, with cancer deaths representing an average of 16.7 years of life lost for each diagnosed Canadian. All sources combined; Canada spends almost $500-million a year on cancer research all in the hope to unravel a path to the C-word—cure. Photograph courtesy of Pexels
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Follow us

Advertise

get help

Subscribe
CloseMenu